FOTI, Daniela Patrizia Francesca
 Distribuzione geografica
Continente #
NA - Nord America 5.176
AS - Asia 3.762
EU - Europa 2.132
SA - Sud America 731
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
Totale 11.884
Nazione #
US - Stati Uniti d'America 4.997
SG - Singapore 1.790
IT - Italia 1.083
CN - Cina 889
BR - Brasile 559
VN - Vietnam 418
IN - India 332
DE - Germania 288
GB - Regno Unito 205
SE - Svezia 132
CA - Canada 110
FI - Finlandia 109
HK - Hong Kong 71
UA - Ucraina 68
AR - Argentina 62
MX - Messico 47
NL - Olanda 46
EC - Ecuador 43
BD - Bangladesh 39
ID - Indonesia 34
RU - Federazione Russa 34
FR - Francia 27
PL - Polonia 27
IQ - Iraq 25
ES - Italia 23
TR - Turchia 17
GR - Grecia 16
PK - Pakistan 16
JP - Giappone 15
KR - Corea 15
CZ - Repubblica Ceca 14
VE - Venezuela 14
PY - Paraguay 12
SA - Arabia Saudita 12
ZA - Sudafrica 12
EG - Egitto 11
AT - Austria 10
CL - Cile 10
UZ - Uzbekistan 10
AU - Australia 9
JO - Giordania 9
UY - Uruguay 9
AZ - Azerbaigian 8
DZ - Algeria 8
IR - Iran 8
PH - Filippine 8
CO - Colombia 7
EU - Europa 7
KE - Kenya 7
TN - Tunisia 7
BG - Bulgaria 6
BO - Bolivia 6
IL - Israele 6
NP - Nepal 6
PE - Perù 6
RO - Romania 6
EE - Estonia 5
GH - Ghana 5
IE - Irlanda 5
MY - Malesia 5
RS - Serbia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
HN - Honduras 4
JM - Giamaica 4
MA - Marocco 4
BE - Belgio 3
CH - Svizzera 3
GY - Guiana 3
KZ - Kazakistan 3
LV - Lettonia 3
SN - Senegal 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AM - Armenia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
LT - Lituania 2
MK - Macedonia 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MT - Malta 1
NA - Namibia 1
Totale 11.872
Città #
San Jose 941
Singapore 612
Ashburn 522
Chandler 506
Dallas 494
Santa Clara 294
Bengaluru 250
Hefei 247
Munich 217
Milan 215
Princeton 196
Lawrence 195
Ho Chi Minh City 146
Beijing 130
London 121
Wilmington 113
Chicago 107
Hanoi 93
Turku 77
Los Angeles 72
Hong Kong 71
Ottawa 69
Catanzaro 65
Des Moines 62
São Paulo 55
Boardman 47
Rome 47
Shanghai 45
New York 40
Council Bluffs 36
Naples 35
Palermo 32
Helsinki 30
Washington 30
Guangzhou 24
Reggio Calabria 23
Boston 22
Orem 21
Redwood City 21
Haiphong 20
Norwalk 19
Brooklyn 18
Da Nang 18
Pune 17
Hanover 16
Rio de Janeiro 16
Bari 15
West Jordan 15
Atlanta 14
Chennai 14
Florence 14
Seattle 14
Warsaw 14
Catania 13
Olomouc 13
Quito 13
San Francisco 13
Shenzhen 13
Tokyo 13
Cosenza 12
Denver 12
Guayaquil 12
Mexico City 12
Amsterdam 11
Manchester 11
Messina 11
Phoenix 11
Redmond 11
San Nicola Manfredi 11
Athens 10
Goiânia 10
Montreal 10
Thái Nguyên 10
Biên Hòa 9
Brasília 9
Montevideo 9
Ninh Bình 9
Tashkent 9
Vallefiorita 9
Ankara 8
Cambridge 8
Charlotte 8
Curitiba 8
Dhaka 8
Secaucus 8
Stockholm 8
Wymondham 8
Amman 7
Baghdad 7
Buffalo 7
Lamezia Terme 7
Mumbai 7
Providence 7
Quảng Ngãi 7
Thái Bình 7
Toronto 7
Baku 6
Belo Horizonte 6
Guarulhos 6
Johannesburg 6
Totale 6.984
Nome #
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study 128
Brain-Behavior-Immune Interaction: Serum Cytokines and Growth Factors in Patients with Eating Disorders at Extremes of the Body Mass Index (BMI) Spectrum 121
First trimester combined test (FTCT) as a predictor of gestational diabetes mellitus 97
MicroRNA-1281 as a novel circulating biomarker in patients with diabetic retinopathy 94
Clinical governance nel laboratorio biomedico 92
Ruolo del fattore di trascrizione AP2 nell’iperespressione del recettore dell’insulina (RI) nel cancro della mammella 91
A Partial Phenotype of adFNDI Related to the Signal Peptide c.55G>A Variant of the AVP Gene 89
Diabetes-Induced Cellular Senescence and Senescence-Associated Secretory Phenotype Impair Cardiac Regeneration and Function Independently of Age 89
Altered circulating marinobufagenin levels and recurrent intradialytic hypotensive episodes in chronic hemodialysis patients: a pilot, prospective study 88
A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components 87
Laboratory parameters of hemostasis, adhesion molecules, and inflammation in type 2 diabetes mellitus: Correlation with glycemic control 86
Impact of legumes and plant proteins consumption on cognitive performances in the elderly 84
Effects of Mediterranean diet supplemented with sylibin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease 82
Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases 82
Dietary Patterns and Fractures Risk in the Elderly 82
diagnostics 79
A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin gene transcription 79
Obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance 79
A modified quantitative EMSA and its application in the study of RNA-protein interactions 77
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 77
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 77
Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors 76
Insights into the World of MicroRNAs 76
Cross-talk among HMGA1 and FoxO1 in control of nuclear insulin signaling 76
Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer 75
- “Cytometric Bead Assay (CBA) e Microarray: confronto tra due nuove metodologie per il dosaggio di Citochine” 74
Cell-line characterization by infrared-induced pyroelectric effect 74
Barriers to postpartum glucose intolerance screening in an Italian population 74
Goldman-Cecil Medicine, 25th edition 74
Early Onset Acceleration of Fetal Growth in Gestational Diabetes Mellitus: Deciding About When and Whom to Screen for Preventing Fetal Macrosomia 74
"Correlazione fra livelli circolanti di adipochine e rimodellamento vascolare nell’ipercolesterolemia combinata familiare” 73
Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years 73
Endocrines 71
Pyroelectric Sensor for Characterization of Biological Cells 71
The role of hormonal, metabolic and inflammatory biomarkers on sleep and appetite in drug free patients with major depression: A systematic review 71
Laboratory evaluation of the efficacy of ticagrelor in patients with acute coronary syndrome (ACS) 71
EPCs CIRCULATING LEVELS IN ESSENTIAL HYPERTENSION 71
Does NUCB2/Nesfatin-1 Influence Eating Behaviors in Obese Patients with Binge Eating Disorder? Toward a Neurobiological Pathway 70
LOW CIRCULATING LEVELS OF CARDIO-REGULATORY MIRNAS PREDICT WORSE OUTCOMES IN HEMODIALYSIS PATIENTS 70
HMGA1 is a novel candidate gene for myocardial infarction susceptibility 70
High Vegetable Fats Intake Is Associated with High Resting Energy Expenditure in Vegetarians 69
Appropriate timing of gestational diabetes mellitus diagnosis in medium- And low-risk women: Effectiveness of the Italian NHS recommendations in preventing fetal macrosomia 69
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis 68
Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy 68
Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients 68
Anemia in the Elderly: A Laboratory Evaluation in Hospitalized and Non-Hospitalized Patients 67
The correct renal function evaluation in patients with thyroid dysfunction 67
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients 66
A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression 66
Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes Mellitus 66
The link between nutritional parameters and bone mineral density in women: results of a screening programme for osteoporosis 65
Mutational Analysis of the AVP Gene in a Calabrian Family Affected by adFNDI 65
2-s2.0-85151325029 64
Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes 64
Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options 63
Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study 63
Activator protein-2 (AP-2) overexpression leading to increased insulin receptor (IR) expression is a critical event in human breast cancer 63
HMGA1 Deficiency—A Common Causal Link between Tau Pathology and Insulin Resistance? 62
The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study 62
Early Effects of a Hypocaloric, Mediterranean Diet on Laboratory Parameters in Obese Individuals 62
Cystatin C, a Controversial Biomarker in Hypothyroid Patients under Levothyroxine Therapy: THYRenal, a Pilot Cohort Observational Study 62
MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot Study 61
Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links 61
A nucleoprotein complex containing Sp1, C/EBPb, and HMGI(Y) controls human insulin receptor gene transcription 61
A new predictive tool for the early risk assessment of gestational diabetes mellitus 61
Long-term effectiveness of liraglutide for weight management and glycemic control in type 2 diabetes 61
Icariin protects H9c2 rat cardiomyoblasts from doxorubicin-induced cardiotoxicity: Role of caveolin-1 upregulation and enhanced autophagic response 61
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance 61
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 61
Circulating Thrombospondin-1 and Endothelin-1 Levels Tend to Decline with Increasing Obesity Severity in Women: Evidence from a Pilot, Cross-Sectional Study 60
Insulin and osteocalcin: further evidence for a mutual cross-talk 60
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 60
Coexistence of Hashimoto’s Thyroiditis in Differentiated Thyroid Cancer: Post-Operative Monitoring of Anti-Thyroglobulin Antibodies and Assessment of Treatment Response 60
Antineoplastic effects of PPARg and thiazolidinedione-PPARg agonists 59
Hypovitaminosis D and low urinary tract symptoms in a female population 59
Gestational diabetes mellitus: an updated overview 58
Pòlimorfismo del gene HMGA1, metodo di individuazione e metodo di diagnosi genetica di insulino-resistenza e/o diabete mellito di tipo 2 58
The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1 58
Laboratory Medicine to improve biological therapeutic treatment 57
Linking Hypoxia to Obesity 57
CIRCULATING MIRNAS: A DIAGNOSTIC AND PROGNOSTIC TOOL IN TYPE 2 DIABETES MELLITUS (T2DM) 57
Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease 57
Effects of a weight-bearing exercise training on bone mineral density and neuromuscular function of osteopenic women 57
Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy 57
“Effetti della dieta sui parametri di laboratorio in pazienti con Sindrome Metabolica” 56
Insulin receptor overexpression in human breast cancer: a new role for the activator protein-2 (ap-2) transcription factor 56
P1422CATHEPSIN-K IS A POWERFUL DIAGNOSTIC BIOMARKER IN PARATHYROIDECTOMIZED DIALYSIS PATIENTS 56
Insulin resistance and cancer: In search for a causal link 56
Glucose biosensors in clinical practice: Principles, limits and perspectives of currently used devices 56
Very low urinary marinobufagenin excretion reflects a high risk of disease progression in non-advanced CKD 55
Predicting accelerated fetal growth in pregnancy: beyond maternal hyperglycemia – The role of prothymosin-α, inflammatory cytokines, and angiogenic factors 55
Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance 55
Predicting the response to SGLT-2 inhibitors as add-on therapy to multiple day injection insulin with glycated albumin: a pilot study 54
Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes 54
Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients 54
Plasma or Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL): Which Is Better at Detecting Chronic Kidney Damage in Type 2 Diabetes? 54
Clinical Risk Factors and First Gestational 75g OGTT May Predict Recurrent and New-Onset Gestational Diabetes in Multiparous Women 53
Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question 53
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients 53
Effects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects 52
Totale 6.847
Categoria #
all - tutte 112.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 0 0 0 0 21
2021/2022581 17 5 11 115 34 12 28 121 67 54 97 20
2022/20231.587 413 145 37 129 119 130 24 105 272 91 96 26
2023/2024811 114 103 86 54 63 217 27 18 12 37 26 54
2024/20252.860 359 194 161 139 183 349 87 81 342 118 331 516
2025/20265.667 314 653 698 939 579 271 621 421 581 411 149 30
Totale 12.275